TRANSPLANT Act of 2021 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021

S 288 TRANSPLANT Act of 2021 Timely ReAuthorization of Necessary Stem cell Programs Lends Access to Needed Therapies Act of 2021

US Congress 117th Congress

TRANSPLANT Act of 2021 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021
S.288

About S.288

A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

  

Bill Texts

Introduced 03/03/2021

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Spread the Word!

Gettr Embed Code

Sponsors (5)

Sen. Jack Reed


Primary Sponsor

Sen. Richard Burr


Co-Sponsor

Sen. Tammy Duckworth


Co-Sponsor

Sen. Tim Scott


Co-Sponsor

Sen. Tina Smith


Co-Sponsor

Track This Bill

Get notified when this bill is updated

Sponsors by party

     

Bill Sponsors

History

Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions.

02/08/2021

Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. (sponsor Introductory Remarks On Measure: Cr S575)

02/08/2021

Subject(s)

Health Advisory Bodies Blood And Blood Diseases Cell Biology And Embryology Congressional Oversight Government Studies And Investigations Health Programs Administration And Funding Medical Research Organ And Tissue Donation And Transplantation Research Administration And Funding